Eurofins Expands Asia Pacific Capacity with a New State-of-the-Art Food Testing Laboratory in Singapore
September 15 2016 - 4:01AM
Business Wire
Regulatory News:
Eurofins Scientific (EUFI.PA) (Paris:ERF), the global leader in
food and feed testing, announces the opening of a new
state-of-the-art microbiology testing laboratory in Singapore to
serve the thriving food and beverage industry in the region.
Eurofins Food Testing Singapore Pte Ltd was setup in December 2015
to provide analytical services to the sophisticated Singapore
market and serve as a competence center for growing markets in The
Philippines, Thailand and Indonesia.
The new, 557m2 facility is located in Paya Lebar with fast
access to the various competencies and logistical network of the
Group in the region. The facility has already started testing
services for some of the largest global food & beverage
companies present in the region.
To begin with, the laboratory will provide general microbiology
testing for food and water such as APC, Coliform, E. coli, B.
cereus, S. aureus, Yeast and Mold. It is also capable of performing
pathogen analysis for Salmonella, Listeria and Legionella.
Testing is available either locally or through Eurofins
Competence Centers. Our strong international network of world class
laboratories are situated in 39 countries. Major competence centers
include Eurofins Denmark for vitamins and amino acids testing,
Eurofins Dr. Specht Lab Germany for pesticides testing, Eurofins
WEJ Contaminants Lab Germany for mycotoxins, veterinary residues
and organic contaminants tests and Eurofins Genescan Lab Germany
for GMO testing. Equipped with the latest instruments and
proprietary methods, the new laboratory aims to provide the best in
class analytical and microbiological testing solutions to food
service catering industries, food manufacturers and food &
beverage retailers.
Comment from Dr. Gilles Martin, Eurofins CEO: “This new
laboratory is another demonstration of Eurofins' commitment to
expand its Asia Pacific footprint, and support the local industries
by providing world-class analytical services in the region. We
intend to continue to strengthen our presence in Singapore, and the
rest of Asia by rolling-out the Group’s full capabilities and
technical know-how.”
For more information, please visit
www.eurofins.sg
Notes for the editor:
Eurofins – a global leader in bio-analysisEurofins
believes it is the world leader in food, environment and
pharmaceutical products testing and that it is also one of the
global independent market leaders in certain testing and laboratory
services for agroscience, genomics and discovery pharmacology and
for supporting clinical studies. In addition, Eurofins is one of
the significant emerging players in specialty clinical diagnostic
testing in Europe and the USA.
With 25,000 staff in more than 250 laboratories across 39
countries, Eurofins offers a portfolio of over 130,000 validated
analytical methods for evaluating the safety, identity,
composition, authenticity, origin, traceability and purity of
biological substances and products, as well as for innovative
clinical diagnostic. The Group provides its customers with
high-quality services, accurate results on time and expert advice
by its highly qualified staff.
Eurofins is committed to pursuing its dynamic growth strategy by
expanding both its technology portfolio and its geographic reach.
Through R&D and acquisitions, the Group draws on the latest
developments in the field of biotechnology and analytical chemistry
to offer its clients unique analytical solutions and the most
comprehensive range of testing methods.
As one of the most innovative and quality oriented international
players in its industry, Eurofins is ideally positioned to support
its clients’ increasingly stringent quality and safety standards
and the expanding demands of regulatory authorities and healthcare
practitioners around the world.
The shares of Eurofins Scientific are listed on the Euronext
Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg
ERF FP).
Important disclaimer:
This press release contains forward-looking statements and
estimates that involve risks and uncertainties. The forward-looking
statements and estimates contained herein represent the judgement
of Eurofins Scientific’ management as of the date of this release.
These forward-looking statements are not guarantees for future
performance, and the forward-looking events discussed in this
release may not occur. Eurofins Scientific disclaims any intent or
obligation to update any of these forward-looking statements and
estimates. All statements and estimates are made based on the
information available to the Company’s management as of the date of
publication, but no guarantee can be made as to their validity.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160915005548/en/
Sanjay Anugula, Phone: +65 8876 4350Eurofins Food Testing
Singapore Pte. LtdE-mail: SanjayAnugula@eurofins.com
Enerplus (NYSE:ERF)
Historical Stock Chart
From Aug 2024 to Sep 2024
Enerplus (NYSE:ERF)
Historical Stock Chart
From Sep 2023 to Sep 2024